Keystone Symposia

This meeting took place in 2013

Here are the related meetings in 2020:
Obesity and NAFLD: Mechanisms and Therapeutics (B3)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Adipose Tissue Biology (J5)

Organizer(s) Susan K. Fried and Anthony W. Ferrante
January 27—February 1, 2013
Keystone Resort • Keystone, CO USA
Abstract Deadline: Sep 27, 2012
Late Abstract Deadline: Oct 29, 2012
Scholarship Deadline: Sep 27, 2012
Early Registration Deadline: Nov 28, 2012

Supported by the Directors' Fund

Summary of Meeting:
Adipocytes are central players in the development of obesity and associated metabolic syndromes. Key areas of ongoing research in this field focus on basic mechanisms that modulate the lifespan of adipocytes, explain how resident and recruited immune cell populations influence adipose tissue remodeling and metabolic function, contribute to the functional heterogeneity of white as well as brown adipose tissue depots, and link alterations in adipocyte function to disease risk. The next few years will bring the application of new technologies and nextgen sequencing, and will likely yield unanticipated insights into developmental and functional aspects of adipocyte biology. Thus, an important goal of the meeting is to engage researchers from diverse fields to take basic discoveries in adipocyte biology to the next level, including a deepening understanding the etiology of type 2 diabetes through our joint meeting, as well as correlated diseases such as cancer, dementia and asthma. The meeting goals are: 1) to foster cross-talk between basic researchers working on model systems with those studying mammalian models and clinical/translational aspects; 2) to integrate emerging knowledge of the myriad roles of adipose tissue in understanding mechanisms linking the degree of adiposity and adipose tissue distribution to disease; and 3) to disseminate knowledge of new technologies that can deepen and broaden knowledge of adipocyte biology in vivo and in vitro. Attendees will take away a more diverse knowledge of the field and an awareness of potential new mechanistic connections and therapeutic opportunities.

View Meeting Program


Early Career Investigator Travel Award Recipients

Heather P. Tarleton
Loyola Marymount University, USA

Keystone Symposia Future of Science Fund Scholarship Recipients

Laura V. Danai
Koch Institute for Integrative Cancer Research at MIT, USA

Damaris Nadia Lorenzo
University of North Carolina at Chapel Hill, USA

Lynes J. Torres
Boston University, USA

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/National Institute on Aging (NIA) Scholarship Recipients

Sagar P. Bapat
University of California, San Francisco, USA

Ryan Berry
Yale University, USA

Jeremie Boucher
AstraZeneca, Sweden

Kimberly Cox-York
Colorado State University, USA

Nicholas Douris
Beth Israel Deaconess Medical Center, Harvard Medical School, USA

Xingxing Kong
Beth Israel Deaconess Medical Center, Harvard Medical School, USA

David Martin Lasar
ETH Z├╝rich, Switzerland

Yun-Hee Lee
Seoul National University, South Korea

Nuria Martinez-Lopez
Albert Einstein College of Medicine, USA

Steven J. Millership
Imperial College London, UK

Tal Pecht
Ben-Gurion University of the Negev, Israel

Vanessa Pellegrinelli
Cordeliers Research Center, France

Helmut Josef Pelzmann
Institute of Biochemistry, Austria

Elizabeth Pino
Massachusetts General Hospital, USA

Li Qiang
Columbia University Medical Center, USA

Hai-Bin Ruan
University of Minnesota, USA

Juan Sanchez-Gurmaches
University of Massachusetts, USA